---
title: "Inmune Bio (INMB.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/INMB.US/norm.md"
symbol: "INMB.US"
name: "Inmune Bio"
parent: "https://longbridge.com/zh-CN/quote/INMB.US.md"
datetime: "2026-05-21T03:08:12.723Z"
locales:
  - [en](https://longbridge.com/en/quote/INMB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INMB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INMB.US/norm.md)
---

# Inmune Bio (INMB.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2034 | -0.1979 | -0.2434 | -1.05 | -0.4329 |
| ROE | -100.25% | -86.11% | -95.45% | -334.24% | -126.13% |
| 营业收入 | - | 0.0000 | - | - | 50000.00 |
| 净利润 | -5.41M | -5.26M | -6.47M | -24.46M | -9.74M |
| 营业利润 | -5.81M | -5.47M | -7.43M | -8.06M | -9.90M |
| 毛利率 | - | - | - | - | 100.00% |
| 净利率 | - | - | - | - | -19478.00% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 25.82M | 32.35M | 33.36M | 37.68M | 37.80M |
| 权益乘数 | 1.32 | 1.38 | 1.31 | 1.31 | 1.27 |
| 每股净资产 | 0.7382 | 0.8849 | 0.9546 | 1.09 | 1.29 |
| 资产周转率 | 0.0000 | 0.0014 | 0.0012 | 0.0011 | 0.0012 |
| 现金及短投 | 21.36M | 24.75M | 27.73M | 33.37M | 19.34M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 2.31M | 1.87M | 1.94M | 1.08M | 278000.00 |
| 净债务 | -19.85M | -23.72M | -26.65M | -32.92M | -18.99M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -3.40M | -2.94M | -5.44M | -7.38M | -6.82M |
| 投资现金流 | - | -143000.00 | -193000.00 | -706000.00 | - |
| 融资现金流 | - | 67000.00 | 0.0000 | 22.27M | 5.27M |
| 自由现金流 | -1.52M | -1.50M | -3.57M | -4.66M | -3.30M |
| 现金流充裕率 | - | -2058.74% | -2818.13% | -1044.62% | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | -143000.00 | -193000.00 | -706000.00 | - |